Verisante Technology Inc.
VRSEF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$439.38K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $439,380.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 4.16 |
| Outstanding Shares | 43,938,004 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0.66 |
|---|---|
| PEG | -1.09 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
October 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Verisante Technology Inc.
18 employees
CEO: Thomas A. Braun
Verisante Technology Inc. presently lacks substantial business operations. Historically, the company focused on developing and manufacturing advanced diagnostic devices for cancer. Originally founded as T-Ray Science Inc., it adopted its...